Insider Transactions in Q4 2025 at Boston Scientific Corp (BSX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 28
2025
|
Miriam O'Sullivan SVP, Chief HR Officer |
SELL
Bona fide gift
|
Direct |
260
-1.73%
|
-
|
|
Nov 14
2025
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Bona fide gift
|
Direct |
9,610
-5.41%
|
-
|
|
Nov 12
2025
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Bona fide gift
|
Direct |
690
-0.39%
|
-
|
|
Nov 06
2025
|
Ellen M Zane Director |
SELL
Open market or private sale
|
Direct |
12,891
-34.82%
|
$1,263,318
$98.28 P/Share
|
|
Nov 03
2025
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Open market or private sale
|
Direct |
50,000
-7.76%
|
$4,950,000
$99.88 P/Share
|
|
Nov 03
2025
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+17.96%
|
$1,300,000
$26.15 P/Share
|
|
Oct 30
2025
|
Michael F Mahoney Chairman, President & CEO |
SELL
Bona fide gift
|
Indirect |
149,992
-41.24%
|
-
|
|
Oct 29
2025
|
Ellen M Zane Director |
BUY
Other acquisition or disposition
|
Direct |
12,891
+25.83%
|
-
|
|
Oct 29
2025
|
Michael F Mahoney Chairman, President & CEO |
BUY
Bona fide gift
|
Indirect |
162,193
+20.12%
|
-
|
|
Oct 28
2025
|
Ellen M Zane Director |
SELL
Open market or private sale
|
Direct |
2,901
-10.73%
|
$295,902
$102.24 P/Share
|
|
Oct 27
2025
|
Ellen M Zane Director |
SELL
Open market or private sale
|
Direct |
9,990
-26.98%
|
$1,008,990
$101.13 P/Share
|
|
Oct 01
2025
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Open market or private sale
|
Direct |
50,000
-11.29%
|
$4,900,000
$98.65 P/Share
|
|
Oct 01
2025
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+17.96%
|
$1,300,000
$26.15 P/Share
|